Skip to content

Comparison of two analgetic-regiments in neurosurgical spinal fusions and the effect of these on the postoperative opioid consumption

Comparison of two analgetic-regiments in neurosurgical spinal fusions and the effect of these on the postoperative opioid consumption - "iSpine"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00028592
Enrollment
100
Registered
2022-03-21
Start date
2022-06-03
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M47 M54

Interventions

Group 1: intravenous analgesia Group 2: intravenous analgesia with an intrathecal singleshot

Sponsors

Charité - Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. given written informed consent 2. elective dorsal spinal fusion at th10 and downwards, maximum of 3 levels 3. age >18 years

Exclusion criteria

Exclusion criteria: 1. No written informed consent 2. Age 3 weeks and >70 mg oral morphin äquivalent 5. no german speakers 6. not able to give informed consent 7. not allowing the saving and using of personal, medical data

Design outcomes

Primary

MeasureTime frame
Cumulative opioid consumption after 24 hours per patient, calculated in oral morphin äquivalents.

Secondary

MeasureTime frame
1. overall opioid consumption after 36 / 48 hours 2. PONV on the first / second postoperative days 3. time of first defacation 4. length of stay in post anesthesia ward 5. intensity of pain between patients 6. length of hospital stay 7. complications (respiratory failure, emergency surgery, postoperative infection, thrombosis) 8. measurement of inflammatory blood parameters before/after surgery, after 24 and 72 hours. 9. postoperative mobilisation with the physiotherapists

Countries

Germany

Contacts

Public ContactSascha Treskatsch

Klinik für Anästhesie und operative IntensivmedizinCampus Benjamin FranklinCharité - Universitätsmedizin Berlin

sascha.treskatsch@charite.de030 450551522

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026